IBDEI2W6 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46127,1,3,0)
;;=3^Myopia,Bilateral
;;^UTILITY(U,$J,358.3,46127,1,4,0)
;;=4^H52.13
;;^UTILITY(U,$J,358.3,46127,2)
;;=^5006266
;;^UTILITY(U,$J,358.3,46128,0)
;;=H52.03^^176^2300^33
;;^UTILITY(U,$J,358.3,46128,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46128,1,3,0)
;;=3^Hypermetropia,Bilateral
;;^UTILITY(U,$J,358.3,46128,1,4,0)
;;=4^H52.03
;;^UTILITY(U,$J,358.3,46128,2)
;;=^5006262
;;^UTILITY(U,$J,358.3,46129,0)
;;=H52.4^^176^2300^45
;;^UTILITY(U,$J,358.3,46129,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46129,1,3,0)
;;=3^Presbyopia
;;^UTILITY(U,$J,358.3,46129,1,4,0)
;;=4^H52.4
;;^UTILITY(U,$J,358.3,46129,2)
;;=^98095
;;^UTILITY(U,$J,358.3,46130,0)
;;=H25.11^^176^2300^10
;;^UTILITY(U,$J,358.3,46130,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46130,1,3,0)
;;=3^Cataract,Nuclear Age-Rel,Right Eye
;;^UTILITY(U,$J,358.3,46130,1,4,0)
;;=4^H25.11
;;^UTILITY(U,$J,358.3,46130,2)
;;=^5005284
;;^UTILITY(U,$J,358.3,46131,0)
;;=H25.12^^176^2300^9
;;^UTILITY(U,$J,358.3,46131,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46131,1,3,0)
;;=3^Cataract,Nuclear Age-Rel,Left Eye
;;^UTILITY(U,$J,358.3,46131,1,4,0)
;;=4^H25.12
;;^UTILITY(U,$J,358.3,46131,2)
;;=^5005285
;;^UTILITY(U,$J,358.3,46132,0)
;;=Z98.49^^176^2300^8
;;^UTILITY(U,$J,358.3,46132,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46132,1,3,0)
;;=3^Cataract Extraction Status,Unspec Eye
;;^UTILITY(U,$J,358.3,46132,1,4,0)
;;=4^Z98.49
;;^UTILITY(U,$J,358.3,46132,2)
;;=^5063739
;;^UTILITY(U,$J,358.3,46133,0)
;;=H04.123^^176^2300^23
;;^UTILITY(U,$J,358.3,46133,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46133,1,3,0)
;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
;;^UTILITY(U,$J,358.3,46133,1,4,0)
;;=4^H04.123
;;^UTILITY(U,$J,358.3,46133,2)
;;=^5004465
;;^UTILITY(U,$J,358.3,46134,0)
;;=H01.009^^176^2300^6
;;^UTILITY(U,$J,358.3,46134,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46134,1,3,0)
;;=3^Blepharitis,Unspec
;;^UTILITY(U,$J,358.3,46134,1,4,0)
;;=4^H01.009
;;^UTILITY(U,$J,358.3,46134,2)
;;=^5133381
;;^UTILITY(U,$J,358.3,46135,0)
;;=H40.023^^176^2300^31
;;^UTILITY(U,$J,358.3,46135,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46135,1,3,0)
;;=3^Glaucoma Suspect,High Risk,Bilateral
;;^UTILITY(U,$J,358.3,46135,1,4,0)
;;=4^H40.023
;;^UTILITY(U,$J,358.3,46135,2)
;;=^5005730
;;^UTILITY(U,$J,358.3,46136,0)
;;=H40.053^^176^2300^42
;;^UTILITY(U,$J,358.3,46136,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46136,1,3,0)
;;=3^Ocular Hypertension,Bilateral
;;^UTILITY(U,$J,358.3,46136,1,4,0)
;;=4^H40.053
;;^UTILITY(U,$J,358.3,46136,2)
;;=^5005742
;;^UTILITY(U,$J,358.3,46137,0)
;;=E11.9^^176^2300^20
;;^UTILITY(U,$J,358.3,46137,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46137,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,46137,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,46137,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,46138,0)
;;=E11.39^^176^2300^19
;;^UTILITY(U,$J,358.3,46138,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46138,1,3,0)
;;=3^DM Type 2 w/ Ophthalmic Complications
;;^UTILITY(U,$J,358.3,46138,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,46138,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,46139,0)
;;=H59.039^^176^2300^7
;;^UTILITY(U,$J,358.3,46139,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46139,1,3,0)
;;=3^CME Mac Edema,Unspec Eye
;;^UTILITY(U,$J,358.3,46139,1,4,0)
;;=4^H59.039
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2W6 3778 printed Nov 22, 2024@17:47:10 Page 2
IBDEI2W6 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46127,1,3,0)
+2 ;;=3^Myopia,Bilateral
+3 ;;^UTILITY(U,$J,358.3,46127,1,4,0)
+4 ;;=4^H52.13
+5 ;;^UTILITY(U,$J,358.3,46127,2)
+6 ;;=^5006266
+7 ;;^UTILITY(U,$J,358.3,46128,0)
+8 ;;=H52.03^^176^2300^33
+9 ;;^UTILITY(U,$J,358.3,46128,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,46128,1,3,0)
+12 ;;=3^Hypermetropia,Bilateral
+13 ;;^UTILITY(U,$J,358.3,46128,1,4,0)
+14 ;;=4^H52.03
+15 ;;^UTILITY(U,$J,358.3,46128,2)
+16 ;;=^5006262
+17 ;;^UTILITY(U,$J,358.3,46129,0)
+18 ;;=H52.4^^176^2300^45
+19 ;;^UTILITY(U,$J,358.3,46129,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,46129,1,3,0)
+22 ;;=3^Presbyopia
+23 ;;^UTILITY(U,$J,358.3,46129,1,4,0)
+24 ;;=4^H52.4
+25 ;;^UTILITY(U,$J,358.3,46129,2)
+26 ;;=^98095
+27 ;;^UTILITY(U,$J,358.3,46130,0)
+28 ;;=H25.11^^176^2300^10
+29 ;;^UTILITY(U,$J,358.3,46130,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,46130,1,3,0)
+32 ;;=3^Cataract,Nuclear Age-Rel,Right Eye
+33 ;;^UTILITY(U,$J,358.3,46130,1,4,0)
+34 ;;=4^H25.11
+35 ;;^UTILITY(U,$J,358.3,46130,2)
+36 ;;=^5005284
+37 ;;^UTILITY(U,$J,358.3,46131,0)
+38 ;;=H25.12^^176^2300^9
+39 ;;^UTILITY(U,$J,358.3,46131,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,46131,1,3,0)
+42 ;;=3^Cataract,Nuclear Age-Rel,Left Eye
+43 ;;^UTILITY(U,$J,358.3,46131,1,4,0)
+44 ;;=4^H25.12
+45 ;;^UTILITY(U,$J,358.3,46131,2)
+46 ;;=^5005285
+47 ;;^UTILITY(U,$J,358.3,46132,0)
+48 ;;=Z98.49^^176^2300^8
+49 ;;^UTILITY(U,$J,358.3,46132,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,46132,1,3,0)
+52 ;;=3^Cataract Extraction Status,Unspec Eye
+53 ;;^UTILITY(U,$J,358.3,46132,1,4,0)
+54 ;;=4^Z98.49
+55 ;;^UTILITY(U,$J,358.3,46132,2)
+56 ;;=^5063739
+57 ;;^UTILITY(U,$J,358.3,46133,0)
+58 ;;=H04.123^^176^2300^23
+59 ;;^UTILITY(U,$J,358.3,46133,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,46133,1,3,0)
+62 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
+63 ;;^UTILITY(U,$J,358.3,46133,1,4,0)
+64 ;;=4^H04.123
+65 ;;^UTILITY(U,$J,358.3,46133,2)
+66 ;;=^5004465
+67 ;;^UTILITY(U,$J,358.3,46134,0)
+68 ;;=H01.009^^176^2300^6
+69 ;;^UTILITY(U,$J,358.3,46134,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,46134,1,3,0)
+72 ;;=3^Blepharitis,Unspec
+73 ;;^UTILITY(U,$J,358.3,46134,1,4,0)
+74 ;;=4^H01.009
+75 ;;^UTILITY(U,$J,358.3,46134,2)
+76 ;;=^5133381
+77 ;;^UTILITY(U,$J,358.3,46135,0)
+78 ;;=H40.023^^176^2300^31
+79 ;;^UTILITY(U,$J,358.3,46135,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,46135,1,3,0)
+82 ;;=3^Glaucoma Suspect,High Risk,Bilateral
+83 ;;^UTILITY(U,$J,358.3,46135,1,4,0)
+84 ;;=4^H40.023
+85 ;;^UTILITY(U,$J,358.3,46135,2)
+86 ;;=^5005730
+87 ;;^UTILITY(U,$J,358.3,46136,0)
+88 ;;=H40.053^^176^2300^42
+89 ;;^UTILITY(U,$J,358.3,46136,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,46136,1,3,0)
+92 ;;=3^Ocular Hypertension,Bilateral
+93 ;;^UTILITY(U,$J,358.3,46136,1,4,0)
+94 ;;=4^H40.053
+95 ;;^UTILITY(U,$J,358.3,46136,2)
+96 ;;=^5005742
+97 ;;^UTILITY(U,$J,358.3,46137,0)
+98 ;;=E11.9^^176^2300^20
+99 ;;^UTILITY(U,$J,358.3,46137,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,46137,1,3,0)
+102 ;;=3^DM Type 2 w/o Complications
+103 ;;^UTILITY(U,$J,358.3,46137,1,4,0)
+104 ;;=4^E11.9
+105 ;;^UTILITY(U,$J,358.3,46137,2)
+106 ;;=^5002666
+107 ;;^UTILITY(U,$J,358.3,46138,0)
+108 ;;=E11.39^^176^2300^19
+109 ;;^UTILITY(U,$J,358.3,46138,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,46138,1,3,0)
+112 ;;=3^DM Type 2 w/ Ophthalmic Complications
+113 ;;^UTILITY(U,$J,358.3,46138,1,4,0)
+114 ;;=4^E11.39
+115 ;;^UTILITY(U,$J,358.3,46138,2)
+116 ;;=^5002643
+117 ;;^UTILITY(U,$J,358.3,46139,0)
+118 ;;=H59.039^^176^2300^7
+119 ;;^UTILITY(U,$J,358.3,46139,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,46139,1,3,0)
+122 ;;=3^CME Mac Edema,Unspec Eye
+123 ;;^UTILITY(U,$J,358.3,46139,1,4,0)
+124 ;;=4^H59.039
